About 20 states have moved to ban copay accumulators.
An increasing number of patients are receiving copay assistance from drug manufacturers and others to help cover the cost of expensive medications. Until fairly recently, the funding from those programs, which can easily run into the thousands of dollars per year, did not count toward a patient’s deductible or out-of-pocket maximum. As a result, a fair number of patients paid very little if anything out of pocket for expensive drugs. With copay accumulators, pharmacy benefit managers (PBMs) count the copay amounts covered by the copay assistance programs toward a patient’s deductible and out-of-pocket maximum. When the copay assistance program runs out, patients may suddenly have to pay the full price of an expensive drug until they reach the deductible or out-of-pocket maximum of their health insurance policies.
Health insurers and PBMs say the accumulator programs counteract the copay assistance programs, which are helpful to individual patients but undercut formularies, lead to the prescription of expensive drugs and may eventually result in higher premiums. Patient groups say accumulator programs make important drugs more expensive and cause harm because people can’t afford their medications after the copay assistance support runs out and they have to pay full price till the deductible is met.
About 20 states have moved to ban copy accumulators. Patient groups have mounted legal challenges. The federal Help Ensure Lower Patient (HELP) Copay Act, introduced in the House and the Senate, would ban accumulators.
Should copay accumulators be banned?
We want to know what you’re thinking! Every Monday morning the editors of Managed Healthcare Executive are posing a question to our readers about a timely issue in U.S. healthcare. Answers will be published every Friday.
Optimize Your Healthcare Payments with Optum Financial
April 29th 2025Discover how Optum Financial is revolutionizing healthcare payments in our latest whitepaper. Learn how transitioning to electronic payments can reduce administrative costs, streamline claims processing and enhance security.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Healthcare hasn't been a priority of the second Trump administration so far, panelists at the Asembia agreed. Medicaid may loom large, though, as the administration and congressional Republicans look for ways to slash government spending as a way of offsetting major tax cuts.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
What 5 Managed Care Trends Experts Say You’re Not Watching Closely Enough
April 29th 2025Managed Healthcare Executive asked several experts in healthcare and managed care to share the trends they think the industry is overlooking. From rising costs and data challenges to shifts in how care is delivered, these are the issues that could have a major impact — and deserve a closer look.
Read More